Comparison on Asian Cancer Summit criteria and LI-RADS in diagnosis of hepatitis B inflammatory small hepatocellular carcinoma / 中国介入影像与治疗学
Chinese Journal of Interventional Imaging and Therapy
;
(12): 671-674, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-861904
ABSTRACT
Objective:
To compare Asian Oncology Summit (AOS, 2016) criteria and liver imaging reporting and data system (LI-RADS) in diagnosis of hepatitis B inflammatory small hepatocellular carcinoma(sHCC).Methods:
Upper abdominal CT and MR examination were performed in 130 patients with suspected hepatitis B inflammatory sHCC (172 hepatic nodules with diameters ≤30 mm). Taken pathological results as the gold standards, the sensitivity and specificity of AOS standard and LI-RADS for diagnosis of hepatitis B sHCC were calculated.Results:
①For lesions with diameter ≤30 mm, the sensitivity and specificity of AOS criteria was 55.00% (44/80) and 92.39% (85/92), while of Li-RADS grading criteria was 100% (80/80) and 67.39% (62/92), respectively. ②For lesions with diameter <20 mm, the sensitivity and specificity of AOS criteria was 40.00% (10/25) and 94.34% (50/53), of Li-RADS grading criteria was 100% (25/25) and 71.70% (38/53), respectively.Conclusion:
LI-RADS was more sensitive in diagnosis of hepatitis B inflammatory sHCC than AOS criteria, being helpful to early diagnosis and treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
/
Practice guideline
/
Screening study
Language:
Chinese
Journal:
Chinese Journal of Interventional Imaging and Therapy
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS